Trepipam (INNTooltip International Nonproprietary Name; developmental code name SCH-12679) is a dopamine receptor agonist of the benzazepine group that was never marketed.

[1] It acts specifically as an agonist of the dopamine D1 receptor.

[2] It is closed related structurally to fenoldopam, a peripherally acting selective D1 receptor partial agonist which is used as an antihypertensive agent.

This pharmacology-related article is a stub.

You can help Wikipedia by expanding it.